查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598452

组织工程市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

Tissue Engineering Market by Product (Biomaterials, Equipment, Services), Application (Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年组织工程市场价值为431.3亿美元，预计2024年将达到512.1亿美元，复合年增长率为18.82%，到2030年将达到1442.8亿美元。

组织工程是一个跨学科领域，利用生物学、工程学和临床科学的原理来开发受损组织和器官的功能替代品。透过提供传统移植的替代方案，我们的目标是解决捐赠器官的短缺问题并解决重要的医疗保健挑战。其范围包括再生医学、疾病建模、药物测试和体外诊断的应用。主要的最终用途领域是医疗保健行业，特别是整形外科、神经病学和心血管治疗。市场成长的主要驱动力是慢性病盛行率的上升和老年人口的增加。先进的3D生物列印技术、生物材料研发以及干细胞研究等创新正在产生重大影响。此外，政府研究支持和研究经费的增加也产生了正面影响。该领域提供了巨大的商机，特别是在个人化医疗和器官再生方面。为了利用这些机会，公司可以专注于开拓细胞应用和开发创新的支架技术。儘管是一个前景广阔的市场，但它面临着一些挑战，包括高昂的开发成本、监管障碍以及围绕干细胞使用的伦理问题。复製复杂组织结构的技术限制也带来了限制。寻求发展的公司应专注于生物製造和创建更复杂的体外组织模型等领域。组织工程市场的本质是高度创新和快速发展，其特点是不断进行旨在克服当前限制的研究和开发活动。企业必须跟上技术进步和监管变化，建立策略伙伴关係，并投资全面的研发以推动创新。总体而言，该领域潜力巨大，但必须认真克服现有挑战才能实现永续的商业性成功。

主要市场统计
基准年[2023] 431.3亿美元
预测年份 [2024] 512.1亿美元
预测年份 [2030] 1442.8亿美元
复合年增长率（%） 18.82%

市场动态：揭示快速发展的组织工程市场的关键市场洞察

供需的动态交互作用正在改变组织工程市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 组织工程治疗不可逆组织损伤的潜在需求
    • 由于肾臟疾病和文明病的增加，需要有效的再生治疗
    • 在先进组织工程应用中增加生物来源基奈米颗粒的使用
  • 市场限制因素
    • 缺乏适当的生物材料和技术来捕捉适当的生理结构
  • 市场机会
    • 3D组织工程领域的技术进步
    • 政府对组织工程研究计划的支持快速增加
  • 市场挑战
    • 与组织工程相关的严格政府法规

波特五力：驾驭组织工程市场的策略工具

波特的五力架构是了解组织工程市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解组织工程市场的外部影响

外部宏观环境因素在塑造组织工程市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解组织工程市场的竞争状况

组织工程市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵组织工程市场供应商的绩效评估

FPNV定位矩阵是评估组织工程市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了组织工程市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，组织工程市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 潜在需要组织工程程序来治疗不可逆的组织损伤
      • 由于肾臟疾病和文明病的增加，需要有效的再生治疗
      • 在先进组织工程应用中增加生物奈米颗粒的使用
    • 抑制因素
      • 缺乏适当的生物材料和技术来捕捉适当的生理结构
    • 机会
      • 3D组织工程领域的技术进步
      • 政府对组织工程研究计划的支持激增
    • 任务
      • 与组织工程相关的严格政府法规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章组织工程市场：副产品

  • 生物材料
    • 细胞来源
    • 生长因子和生物活性分子
    • 鹰架材料
      • 复合脚手架材料
      • 奈米支架材料
      • 天然生物支架材料
      • 合成生物分解性高分子支架材料
  • 装置
    • 反应器
    • 细胞培养室
    • 成像和流式细胞仪
  • 服务

第七章组织工程市场：依应用分类

  • 心血管应用
  • 牙科和颅颜外科应用
  • 药物测试和开发
  • 整形外科应用
  • 再生医学
  • 伤口癒合

第八章组织工程市场：依最终使用者分类

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约调查机构

第九章美洲组织工程市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区组织工程市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲组织工程市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 3D BioFibR 推出两款 CollaFibR 组织工程产品，进入生物列印和 3D 细胞培养市场。
    • Essent Biologics 推出创新的人体天然组织来源的 I 型胶原蛋白
    • BioMed X 与艾伯维 (AbbVie) 扩大免疫学和组织工程领域的研究合作
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Aspect Biosystems Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Corning Incorporated
  • CTIBiotech
  • Frequency Therapeutics
  • Gel4Med
  • General Electric Company
  • Humacyte, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Miromatrix Medical, Inc.
  • Modern Meadow
  • Novartis AG
  • Organogenesis Inc.
  • Organovo Holdings, Inc.
  • Pfizer Inc.
  • Prellis Biologics
  • ReproCell Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regeneration Systems Inc.
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0315DDADCE14

The Tissue Engineering Market was valued at USD 43.13 billion in 2023, expected to reach USD 51.21 billion in 2024, and is projected to grow at a CAGR of 18.82%, to USD 144.28 billion by 2030.

Tissue engineering is a multidisciplinary field that harnesses principles from biology, engineering, and clinical sciences to develop functional substitutes for damaged tissues and organs. It aims to solve significant healthcare challenges by offering alternatives to traditional transplantations, thereby addressing the shortage of donor organs. The scope includes applications in regenerative medicine, disease modeling, drug testing, and in vitro diagnostics. Key end-use segments are in the healthcare industry, particularly in orthopedics, neurology, and cardiovascular treatments. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing geriatric population. Technological innovations-such as advanced 3D bioprinting techniques, development of biomaterials, and stem cell research-serve as significant influencers. Furthermore, increasing governmental support and funding for research contribute positively. The field offers substantial opportunities, particularly in personalized medicine and organ regeneration. To capitalize on these opportunities, businesses can focus on pioneering stem cell applications and developing innovative scaffold technologies. Despite its promising prospects, the market faces several challenges, including high development costs, regulatory hurdles, and ethical concerns surrounding stem cell use. Limitations also arise from technological constraints in replicating complex tissue structures. Companies aiming for growth should focus on areas like biofabrication and the creation of more sophisticated in vitro tissue models. The nature of the tissue engineering market is highly innovative and rapidly evolving, characterized by constant research and development activities aimed at overcoming current limitations. Businesses must stay abreast of technological advances and regulatory changes while forging strategic partnerships and investing in comprehensive R&D to drive innovation. Overall, the field holds vast potential, but it requires careful navigation through existing challenges to achieve sustainable commercial success.

KEY MARKET STATISTICS
Base Year [2023] USD 43.13 billion
Estimated Year [2024] USD 51.21 billion
Forecast Year [2030] USD 144.28 billion
CAGR (%) 18.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Engineering Market

The Tissue Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential need for tissue engineering procedures in treating irreversible damage of tissues
    • Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
    • Growing use of biogenic nanoparticles for advanced tissue engineering applications
  • Market Restraints
    • Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
  • Market Opportunities
    • Technological advancements in the field of 3D tissue engineering
    • Surging government support for tissue engineering research projects
  • Market Challenges
    • Stringent government regulations associated with tissue engineering

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Engineering Market

A detailed market share analysis in the Tissue Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Engineering Market

A strategic analysis of the Tissue Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspect Biosystems Ltd., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Cook Group Incorporated, Corning Incorporated, CTIBiotech, Frequency Therapeutics, Gel4Med, General Electric Company, Humacyte, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Miromatrix Medical, Inc., Modern Meadow, Novartis AG, Organogenesis Inc., Organovo Holdings, Inc., Pfizer Inc., Prellis Biologics, ReproCell Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regeneration Systems Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Biomaterials, Equipment, and Services. The Biomaterials is further studied across Cell Sources, Growth Factors & Bioactive Molecules, and Scaffold Materials. The Scaffold Materials is further studied across Composite Scaffold Materials, Nano-Scaffold Materials, Natural Biological Scaffold Materials, and Synthetic Biodegradable Polymer Scaffold Materials. The Equipment is further studied across Bioreactors, Cell Culture Chambers, and Image & Flow Cytometers.
  • Based on Application, market is studied across Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development, Orthopedic Applications, Regenerative Medicine, and Wound Healing.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential need for tissue engineering procedures in treating irreversible damage of tissues
      • 5.1.1.2. Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
      • 5.1.1.3. Growing use of biogenic nanoparticles for advanced tissue engineering applications
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the field of 3D tissue engineering
      • 5.1.3.2. Surging government support for tissue engineering research projects
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations associated with tissue engineering
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Engineering Market, by Product

  • 6.1. Introduction
  • 6.2. Biomaterials
    • 6.2.1. Cell Sources
    • 6.2.2. Growth Factors & Bioactive Molecules
    • 6.2.3. Scaffold Materials
      • 6.2.3.1. Composite Scaffold Materials
      • 6.2.3.2. Nano-Scaffold Materials
      • 6.2.3.3. Natural Biological Scaffold Materials
      • 6.2.3.4. Synthetic Biodegradable Polymer Scaffold Materials
  • 6.3. Equipment
    • 6.3.1. Bioreactors
    • 6.3.2. Cell Culture Chambers
    • 6.3.3. Image & Flow Cytometers
  • 6.4. Services

7. Tissue Engineering Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Applications
  • 7.3. Dental & Craniofacial Applications
  • 7.4. Drug Testing & Development
  • 7.5. Orthopedic Applications
  • 7.6. Regenerative Medicine
  • 7.7. Wound Healing

8. Tissue Engineering Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Tissue Engineering Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Engineering Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineering Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
    • 12.3.2. Essent Biologics Launches Revolutionary Human Native Tissue-Derived Type I Collagen
    • 12.3.3. BioMed X Extends Research Collaboration ith AbbVie On Immunology And Tissue Engineering
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aspect Biosystems Ltd.
  • 3. B. Braun SE
  • 4. Baxter International Inc.
  • 5. Bayer AG
  • 6. Becton, Dickinson and Company
  • 7. Cook Group Incorporated
  • 8. Corning Incorporated
  • 9. CTIBiotech
  • 10. Frequency Therapeutics
  • 11. Gel4Med
  • 12. General Electric Company
  • 13. Humacyte, Inc.
  • 14. Integra LifeSciences Corporation
  • 15. Johnson & Johnson Services, Inc.
  • 16. Medtronic PLC
  • 17. Merck KGaA
  • 18. Miromatrix Medical, Inc.
  • 19. Modern Meadow
  • 20. Novartis AG
  • 21. Organogenesis Inc.
  • 22. Organovo Holdings, Inc.
  • 23. Pfizer Inc.
  • 24. Prellis Biologics
  • 25. ReproCell Inc.
  • 26. Smith & Nephew PLC
  • 27. Stryker Corporation
  • 28. Tissue Regeneration Systems Inc.
  • 29. Vericel Corporation
  • 30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. TISSUE ENGINEERING MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE ENGINEERING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE ENGINEERING MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROWTH FACTORS & BIOACTIVE MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COMPOSITE SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NATURAL BIOLOGICAL SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC BIODEGRADABLE POLYMER SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE CHAMBERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY IMAGE & FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DENTAL & CRANIOFACIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DRUG TESTING & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 285. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023